top of page

NCI-2024-03914

Phase 1 Trial of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Activity of RP-1664 in Participants with Advanced Solid Tumors


This Phase 1 clinical trial investigates RP-1664 in participants with advanced solid tumors. The study focuses on assessing the safety, pharmacokinetics (how the drug moves in the body), pharmacodynamics (how the drug affects the body), and initial clinical activity of RP-1664. The goal is to understand how well the drug works and its safety profile in treating advanced solid tumors.


For more information about the trial, click the link below:

Clinical Trial Site: Columbia


To see all available clinical trials click here.



Recent Posts

See All

NCI-2021-10597

A Phase 1 Open-Label, Dose-Escalation and Cohort Expansion Study of LUNA18 Monotherapy and Combination Therapy in Patients with Locally...

NCI-2022-10927

A Phase I, Multicenter, Open-label, First-in Human, Dose Escalation and Expansion Study of AZD9592 as Monotherapy and in Combination with...

NCT-05753722

An Open-Label Phase 1 Dose-Escalation and Expansion Study Investigating the Safety,Pharmacokinetics, Pharmacodynamics, and Activity of...

コメント


bottom of page